Home » Topics » Regulatory » Patents

Patents
RSS

Novel thrombin inhibitors discovered by AstraZeneca researchers

Feb. 10, 2009

Recent Roche patents divulge new trace amine receptor 1 ligands

Feb. 10, 2009

Roche researchers discover novel GABA-A alpha5 receptor ligands

Feb. 10, 2009

New PI3K inhibitors imparted in recent UCB patent

Feb. 10, 2009

Inhibitors of HIV reverse transcriptase under development at Yale University

Feb. 9, 2009

U.S. Department of Health & Human Services divulges new antibacterial PSMalpha peptides

Feb. 9, 2009

New orexin receptor antagonists imparted by GSK for sleep disorders

Feb. 9, 2009

Novel gamma-secretase inhibitors patented by Schering-Plough for treating Alzheimer's disease

Feb. 9, 2009

Merck KGaA presents novel PDK1 inhibitors with oncolytic properties

Feb. 9, 2009

Novel PDF inhibitors prepared and tested at Il-Dong

Feb. 6, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...